ORMP
Oramed Pharmaceuticals Inc
4.20$
-3.9%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | 100.0% | – | – | – | – | – | – | |
| – | 30.7% | – | – | – | – | – | 13.9% | – | 5.2% | 8.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 99.4% | – | – | – | – | – | – | |
| 100.0% | 69.3% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 86.1% | 100.0% | 94.8% | 91.7% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | 0.7% | – | – | – | – | – | – | |
| 788.4% | 385.7% | 511.5% | 367.4% | 410.4% | 380.9% | 451.0% | 679.7% | 443.1% | 645.0% | 467.6% | 566.1% | 323.1% | 300.0% | 492.6% | 282.7% | 435.8% | 856.7% | 581.8% | 807.9% | 855.6% | 951.0% | 876.3% | 1,361.9% | 784.0% | 1,068.6% | 664.7% | 270.2% | – | – | – | – | – | – | 110.3% | – | – | – | – | – | – | |
| 175.4% | 76.7% | 139.3% | 81.8% | 151.3% | 166.3% | 164.1% | 169.0% | 167.4% | 138.3% | 159.9% | 131.8% | 121.3% | 160.4% | 206.4% | 151.2% | 107.2% | 107.9% | 250.2% | 190.5% | 329.3% | 258.0% | 824.6% | 375.7% | 448.8% | 400.3% | 189.6% | 363.8% | – | – | – | – | – | – | 115.4% | – | – | – | – | – | – | |
| 963.7% | 462.5% | 650.7% | 449.3% | 561.7% | 547.1% | 615.1% | 848.8% | 610.5% | 783.2% | 627.5% | 697.9% | 444.3% | 460.4% | 699.0% | 433.9% | 543.0% | 964.5% | 832.0% | 998.4% | 1,184.9% | 1,295.8% | 1,789.5% | 1,793.9% | 1,300.7% | 1,530.2% | 882.0% | 662.5% | – | – | – | – | – | – | 225.7% | – | – | – | – | – | – | |
| -1,002.5% | -393.1% | -550.7% | -349.3% | -461.7% | -447.1% | -515.1% | -734.8% | -510.5% | -688.4% | -535.7% | -597.9% | -344.3% | -360.4% | -599.0% | -333.9% | -443.0% | -864.5% | -732.0% | -898.4% | -1,084.9% | -1,195.8% | -1,689.5% | -1,693.9% | -1,200.7% | -1,430.2% | -782.0% | -562.5% | – | – | – | – | – | – | -225.0% | – | – | – | – | – | – | |
| 378.2% | 3.9% | 3.4% | 3.2% | – | 3.4% | 3.6% | 4.7% | – | 1.2% | 2.9% | 2.1% | – | 3.0% | 0.3% | 1.2% | 20.0% | 1.8% | 39.1% | 72.4% | 98.0% | 26.0% | 81.7% | 51.9% | 151.9% | 239.9% | 239.8% | 0.0% | – | – | – | – | – | – | 127.9% | – | – | – | – | – | – | |
| -970.3% | -366.6% | -520.9% | -318.5% | -436.2% | -414.2% | -482.8% | -705.7% | -474.2% | -638.3% | -510.7% | -597.1% | -334.8% | -377.3% | -547.2% | -335.4% | -439.9% | -826.4% | -692.9% | -826.0% | -1,052.1% | -1,201.5% | -1,607.8% | -1,642.0% | -1,048.8% | -1,282.8% | -542.2% | -194.8% | – | – | – | – | – | – | -352.9% | – | – | – | – | – | – | |
| 378.2% | 65.6% | -29.8% | -30.8% | -25.4% | -32.9% | -32.3% | -29.2% | -36.3% | -50.1% | 45.0% | -2.9% | -9.5% | 13.9% | -51.8% | 1.5% | -20.0% | -38.1% | -39.1% | -61.4% | -48.8% | -30.9% | -42.5% | -79.2% | 14.7% | -28.3% | -272.2% | -17.7% | – | – | – | – | – | – | 29.2% | – | – | – | – | – | – | |
| -1,348.4% | -432.1% | -520.9% | -318.5% | -436.2% | -414.2% | -482.8% | -705.7% | -474.2% | -638.3% | -555.7% | -597.1% | -334.8% | -377.3% | -547.2% | -335.4% | -439.9% | -826.4% | -692.9% | -764.6% | -1,003.4% | -1,170.6% | -1,565.3% | -1,562.8% | -1,063.5% | -1,254.5% | -270.0% | -177.2% | – | – | – | – | – | – | -382.1% | – | – | – | – | – | – | |
| -1,095.8% | -362.5% | -517.3% | -314.9% | -558.4% | -410.6% | -478.8% | -700.8% | -615.2% | -645.7% | -494.4% | -559.4% | -398.4% | -329.4% | -598.7% | -333.5% | -478.9% | -824.3% | -727.8% | -894.3% | -1,082.1% | -1,173.7% | -1,687.8% | -1,691.7% | -1,198.5% | -996.9% | -776.4% | -554.7% | – | – | – | – | – | – | -223.5% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.